BEAM THERAPEUTICS INC (BEAM) Stock Income Statement
NASDAQ:BEAM - Nasdaq - US07373V1052 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 63.52M | 377.71M | 60.92M | 51.84M | 20.00K | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 479.09M | 554.19M | 399.40M | 444.31M | 132.78M | |||
| Research and Development | 367.56M | 437.38M | 311.59M | 387.09M | 103.18M | |||
| Selling, General, and Administrative Expenses | 111.53M | 116.81M | 87.81M | 57.22M | 29.61M | |||
| Operating Income | -415.57M | -176.49M | -338.48M | -392.47M | -132.76M | |||
| Interest Income/Expense | 37.27M | 35.58M | 59.40M | -1.01M | -61.83M | |||
| Other Income/Expense | 1.59M | 9.74M | 18.90M | 22.84M | N/A | |||
| Income Before Taxes | -376.70M | -131.16M | -260.18M | -370.64M | -194.59M | |||
| Income Tax | 39.00K | 1.37M | 3.41M | N/A | N/A | |||
| Net Income | -376.74M | -132.53M | -289.09M | -370.64M | -195.87M | |||
| EBITDA | -393.64M | -156.47M | -324.33M | -385.02M | -128.02M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.58 | -1.72 | -4.13 | -5.77 | -4.19 | |||
| Non GAAP EPS | -4.58 | -1.90 | -4.13 | -5.94 | -4.10 | |||
| Statistics | ||||||||
| Profit Margin | -593.13% | -35.09% | -474.54% | -714.97% | -979350.00% | |||
| Operating Profit Margin | -654.25% | -46.73% | -555.61% | -757.08% | -663800.00% | |||
All data in USD